Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Multimodal CT Model: Enhancing Lung Cancer STAS Prediction vs. Unimodal CT

View through CrossRef
Abstract Background Lung cancer is one of the leading causes of cancer-related death worldwide. Tumor spread through air spaces (STAS), a unique invasive pattern of lung cancer, has a direct effect on patient prognosis. Currently, accurately identifying the presence of STAS in patients before surgery remains an unresolved challenge in clinical practice. This study aimed to construct a model for predicting the STAS status of lung cancer patients on the basis of radiomic features, clinical information, and genetic features. Methods A total of 333 lung cancer patients who underwent surgical treatment were enrolled in this study, and they were randomly divided into a training set and a test set at a ratio of 7:3. All the subjects received preoperative computed tomography (CT) scans, with clinical information and genetic data collected simultaneously. After delineating the volume of interest (VOI) of lung tumors, the research team extracted intratumoral radiomic features, 3-mm peritumoral radiomic features, habitat features, and deep learning features from the VOI via open-source Python packages. Multiple radiomic models were constructed via Python by integrating clinical features and genetic features, and the performance of each model was subsequently evaluated via indicators such as the area under the receiver operating characteristic curve (AUC), decision curve analysis (DCA), and calibration curves. Results Fusion Model 1, which was constructed by integrating intratumoral radiomic features and incorporating 3-mm peritumoral radiomic features, habitat features, and deep learning features, demonstrated excellent predictive performance: its AUC value reached 0.96 in the training set and 0.933 in the validation set. Moreover, the model showed favorable net benefit in decision curve analysis (DCA) and extremely strong stability in the calibration curve, indicating high consistency between the predicted and actual probabilities. In addition, the results of this study revealed no significant associations between genetic features and STAS status; among the clinical features, a tumor diameter > 2 cm was strongly correlated with STAS. Conclusions The multimodal model "Fusion Model 1" has demonstrated excellent predictive performance and stable performance, providing important support and new hope for promoting preoperative personalized medical practice and improving the prognosis of lung cancer patients.
Title: Multimodal CT Model: Enhancing Lung Cancer STAS Prediction vs. Unimodal CT
Description:
Abstract Background Lung cancer is one of the leading causes of cancer-related death worldwide.
Tumor spread through air spaces (STAS), a unique invasive pattern of lung cancer, has a direct effect on patient prognosis.
Currently, accurately identifying the presence of STAS in patients before surgery remains an unresolved challenge in clinical practice.
This study aimed to construct a model for predicting the STAS status of lung cancer patients on the basis of radiomic features, clinical information, and genetic features.
Methods A total of 333 lung cancer patients who underwent surgical treatment were enrolled in this study, and they were randomly divided into a training set and a test set at a ratio of 7:3.
All the subjects received preoperative computed tomography (CT) scans, with clinical information and genetic data collected simultaneously.
After delineating the volume of interest (VOI) of lung tumors, the research team extracted intratumoral radiomic features, 3-mm peritumoral radiomic features, habitat features, and deep learning features from the VOI via open-source Python packages.
Multiple radiomic models were constructed via Python by integrating clinical features and genetic features, and the performance of each model was subsequently evaluated via indicators such as the area under the receiver operating characteristic curve (AUC), decision curve analysis (DCA), and calibration curves.
Results Fusion Model 1, which was constructed by integrating intratumoral radiomic features and incorporating 3-mm peritumoral radiomic features, habitat features, and deep learning features, demonstrated excellent predictive performance: its AUC value reached 0.
96 in the training set and 0.
933 in the validation set.
Moreover, the model showed favorable net benefit in decision curve analysis (DCA) and extremely strong stability in the calibration curve, indicating high consistency between the predicted and actual probabilities.
In addition, the results of this study revealed no significant associations between genetic features and STAS status; among the clinical features, a tumor diameter > 2 cm was strongly correlated with STAS.
Conclusions The multimodal model "Fusion Model 1" has demonstrated excellent predictive performance and stable performance, providing important support and new hope for promoting preoperative personalized medical practice and improving the prognosis of lung cancer patients.

Related Results

Abstract 1345: Evidence for genetic mediation of lung cancer through hay fever.
Abstract 1345: Evidence for genetic mediation of lung cancer through hay fever.
Abstract Introduction: In the past decade, advances in genetics have led to the discovery of numerous lung cancer susceptibility variants. The majority of these vari...
Time to Start Up: CT-Basted Radiomics in Children’s Lung Diseases
Time to Start Up: CT-Basted Radiomics in Children’s Lung Diseases
Radiomics is a new interdisciplinary field and a fusion product consisting by large data technology and medical image to aid diagnosis. Radiomics can gather information from differ...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Abstract 1657: Genome-wide association study of lung cancer: Variation in TP63 gene confers the risk of lung adenocarcinoma
Abstract 1657: Genome-wide association study of lung cancer: Variation in TP63 gene confers the risk of lung adenocarcinoma
Abstract Lung cancer is the most common cause of death from cancer worldwide, and its incidence is increasing in East Asian and Western countries. Lung cancer compri...
Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
Purpose: To make a diagnosis of cancer with BDORT (resonance test), we can choose two methods. One is to use a chemical agent like Integrin α5β1 or Oncogene C-f...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract Introduction Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...

Back to Top